Ethosuximide
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1757 publications
Thalamic 5-HT2A Receptor Activation Reduces GABA Uptake, Increases Tonic GABAA Inhibition and Induces Absence Seizures in Wistar Rats.
Journal: Neuropharmacology
Published: May 09, 2026
Interactions between SSR504734, a selective glycine transporter type 1 inhibitor, and antiseizure drugs: pharmacodynamic and pharmacokinetic studies in mice.
Journal: Neuropharmacology
Published: January 28, 2026
The Cure Better Not Be Worse Than the Illness - Lessons From Ethosuximide in Irritable Bowel Syndrome.
Journal: Gastroenterology
Published: January 20, 2026
Ethosuximide and Irritable Bowel Syndrome-Related Abdominal Pain: A Randomized Clinical Trial.
Journal: JAMA network open
Published: January 08, 2026
Psychiatric and behavioural side effects of antiseizure medications in epilepsy.
Journal: Journal of neurology
Published: November 11, 2025
Clinical features associated with a response to ethosuximide in developmental and epileptic encephalopathy with spike wave activation in sleep.
Journal: Epilepsy & behavior : E&B
Published: October 09, 2025
Clinical response to brivaracetam in two cases of drug-resistant juvenile absence epilepsy
Journal: Anales del sistema sanitario de Navarra
Published: August 25, 2025
Site-selective addition of succinimide motif through nitro-assisted C-H functionalization of (hetero) arenes under rhodium catalysis.
Journal: Archives of pharmacal research
Published: August 04, 2025
Last Updated: 06/30/2026